LeMaitre Vascular CEO adds dividend share rights

LeMaitre Vascular’s CEO received multiple small dividend equivalent right accruals tied to prior RSU and PSU awards, with no 10b5-1 plan reported.

Rhea-AI Filing Summary

LEMAITRE VASCULAR INC (LMAT) reported that Chairman and CEO George W. LeMaitre acquired several small blocks of Dividend Equivalent Rights on September 3, 2026. These rights accrued on previously granted restricted stock unit and performance share unit awards from December 2022, December 2023, December 2024, and December 2025 and will vest proportionately with those underlying awards. Each dividend equivalent right is the economic equivalent of one share of LeMaitre Vascular’s common stock, and no Rule 10b5-1 trading plan is reported in connection with these accruals.

Insider Trade Summary

Grant/Award: 71.4165 shares

Grant/Award 7 txns

Insider LeMaitre George W

Role Chairman and CEO

Type	Security	Shares	Price	Value
Grant/Award	Dividend Equivalent Rights F1	4.6726	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights F2	4.6726	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights F3	7.9884	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights F4	9.5728	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights F5	11.6845	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights F6	13.2391	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights F7	19.5865	$0.00	$0.00

Holdings After Transaction: Dividend Equivalent Rights — 425.819 contracts (Direct)

Footnotes (7)

1. F1. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
2. F2. These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
3. F3. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
4. F4. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
5. F5. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
6. F6. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
7. F7. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Key Figures

Dividend equivalent rights accrued (F1/F2 set): 4.6726 rights Dividend equivalent rights accrued (2023 awards): 7.9884 and 9.5728 rights Dividend equivalent rights accrued (2024 awards): 11.6845 and 13.2391 rights +2 more

5 metrics

Dividend equivalent rights accrued (F1/F2 set) 4.6726 rights Accrued September 3, 2026 on 2022 RSU and PSU grants, per footnotes F1 and F2

Dividend equivalent rights accrued (2023 awards) 7.9884 and 9.5728 rights Accrued September 3, 2026 on RSU and PSU grants dated December 8, 2023

Dividend equivalent rights accrued (2024 awards) 11.6845 and 13.2391 rights Accrued September 3, 2026 on RSU and PSU grants dated December 6, 2024

Dividend equivalent rights accrued (2025 award) 19.5865 rights Accrued September 3, 2026 on RSU grant dated December 10, 2025

Rule 10b5-1 plan status No plan reported Document-level checkbox indicates transactions were not under a Rule 10b5-1 plan

Key Terms

Dividend Equivalent Rights, restricted stock unit, performance share unit, economic equivalent

4 terms

Dividend Equivalent Rights financial

"These dividend equivalent rights accrued on a restricted stock unit award"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

restricted stock unit financial

"accrued on a restricted stock unit award granted on 12/12/2022"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

performance share unit financial

"accrued on a performance share unit award granted on 12/12/2022"

A performance share unit (PSU) is a form of executive or employee pay that promises shares (or the cash value of shares) only if the company meets specific performance targets over a set period. Think of it like a bonus cheque that only arrives if the company hits agreed goals — it aligns managers’ rewards with business results and signals to investors how leadership is being incentivized to grow value over time.

economic equivalent financial

"Each dividend equivalent right is the economic equivalent of one share"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did LMAT report for George W. LeMaitre on September 3, 2026?

LeMaitre acquired several small blocks of Dividend Equivalent Rights on September 3, 2026. These rights accrued automatically on previously granted restricted stock unit and performance share unit awards and are economically equivalent to common shares.

What are the largest and smallest dividend equivalent right accruals reported for LMAT’s CEO?

The reported accruals range from 4.6726 dividend equivalent rights up to 19.5865 rights. Each right is the economic equivalent of one common share and vests proportionately with its related equity award.

Are George W. LeMaitre’s LMAT dividend equivalent rights tied to specific prior awards?

Yes. The dividend equivalent rights accrued on restricted stock unit and performance share unit awards originally granted on December 12, 2022, December 8, 2023, December 6, 2024, and December 10, 2025, and will vest proportionately with those awards.

Did LMAT indicate any Rule 10b5-1 trading plan for these insider transactions?

No. The filing indicates that no Rule 10b5-1 trading plan is reported for these transactions. The acquisitions represent automatic accruals of dividend equivalent rights on outstanding equity awards.

Do the LMAT dividend equivalent rights reported give the CEO common shares immediately?

No. The rights are dividend equivalent rights, each the economic equivalent of one common share, and they vest proportionately with the related RSU or PSU awards rather than converting immediately into common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 04:46 PM Accepted by SEC EDGAR 09/08/2026 - 04:46 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LeMaitre George W

(Last) (First) (Middle)

C/O LEMAITRE VASCULAR, INC.

63 SECOND AVENUE

(Street)

BURLINGTON MASSACHUSETTS 01803

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LEMAITRE VASCULAR INC [ LMAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Dividend Equivalent Rights	(1)	09/03/2026		A		4.6726		(1)	(1)	Common Stock	4.6726	$0	54.005	D
Dividend Equivalent Rights	(2)	09/03/2026		A		4.6726		(2)	(2)	Common Stock	4.6726	$0	53.2963	D
Dividend Equivalent Rights	(3)	09/03/2026		A		7.9884		(3)	(3)	Common Stock	7.9884	$0	65.3344	D
Dividend Equivalent Rights	(4)	09/03/2026		A		9.5728		(4)	(4)	Common Stock	9.5728	$0	70.4281	D
Dividend Equivalent Rights	(5)	09/03/2026		A		11.6845		(5)	(5)	Common Stock	11.6845	$0	65.0639	D
Dividend Equivalent Rights	(6)	09/03/2026		A		13.2391		(6)	(6)	Common Stock	13.2391	$0	67.0809	D
Dividend Equivalent Rights	(7)	09/03/2026		A		19.5865		(7)	(7)	Common Stock	19.5865	$0	50.6104	D

Explanation of Responses:

1. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

2. These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

3. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

4. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

5. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

6. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

7. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

	/s/ Douglas G. Bush, Attorney-in-fact	09/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)